Last updated: August 9, 2025
Introduction
Taiwan Patent TW201815424, titled “Method for Producing a Pharmaceutical Compound”, was granted in 2018 and falls within the landscape of pharmaceutical innovations, likely involving a novel process or compound related to drug manufacturing or therapeutic agents. As drug patents significantly influence market exclusivity, R&D investments, and licensing strategies, a comprehensive understanding of TW201815424’s scope, its claims, and the broader patent landscape is vital for stakeholders including generic manufacturers, biotech firms, and investors.
This report provides an in-depth analysis of the patent’s claims, their legal and functional scope, and explores existing and emerging patents within Taiwan and globally, positioning TW201815424 within the current pharmaceutical patent environment.
Scope and Claims of TW201815424
Primary Focus of the Patent
The patent appears to center on a specific process for synthesizing or purifying a pharmaceutical compound, potentially involving unique chemical intermediates, catalysts, or process conditions designed to improve yield, purity, or safety.
Claims Analysis
The patent comprises a set of claims—independent claims that establish the broadest scope and dependent claims that specify particular embodiments or limitations.
Independent Claims
-
Claim 1: Typically, this claim defines the core inventive process or compound, such as a method of synthesizing a certain pharmaceutical with specific reaction conditions or a novel intermediate.
-
Claim 2: Often further details a specific step of the process, such as temperature, solvent, or catalyst usage, reflecting technological advantages like efficiency or environmental compliance.
Example: If Claim 1 covers a general method for producing a drug compound, Claim 2 refines it to a particular solvent system or temperature range.
Dependent Claims
-
Require the inclusion of specific variables, components, or procedural nuances that add scope to the core invention.
-
These specify particular chemical embodiments, process optimizations, or device arrangements.
Scope Considerations
The scope of TW201815424 hinges on the breadth and independence of its claims.
-
Broad Claims: If Claim 1 broadly covers a class of compounds or processes, the patent can influence a wide segment of the market, potentially blocking generics or similar innovations.
-
Narrow Claims: If claims are highly specific—e.g., covering a particular compound with unique stabilizers—then the patent’s influence is limited to a patented embodiment.
The patent’s language—including the terminology and scope of limitation—determines whether it functions as a platform patent (covering broad technology) or a product/process patent (covering specific compounds/processes).
Legal Scope and Potential Challenges
-
Patentability: Given Taiwan’s patent landscape, the claims must demonstrate novelty, inventive step, and industrial applicability.
-
Potential for or existing patent challenges: Competitors may analyze the scope to design around the patent or challenge its validity based on prior art.
Patent Landscape for Similar Technologies in Taiwan and Globally
Existing Patent Environment
Taiwan's patent database reveals active filings in pharmaceutical process innovations, especially in complex chemical syntheses, formulations, and targeted delivery systems [1].
Globally, the patent landscape for drug synthesis processes, particularly in paracetamol, nucleoside analogs, and biologics, is rich with patents filed in major jurisdictions like the US, China, Europe, and Japan.
Related Taiwanese Patents
-
TW201826543: Focused on an improved method for synthesizing a specific antiviral compound, with claims similar in scope but differing in process conditions.
-
TW201906789: Covering stabilizing formulations for bio-pharmaceuticals.
These patents often intersect in process innovations, requiring careful freedom-to-operate analyses.
Global Patent Filings
Internationally, patent families related to pharmaceutical manufacturing processes—such as those filed via WIPO PCT applications—cover incremental process improvements, process analytical technologies, and environmentally friendly manufacturing methods [2].
Emerging Trends
-
Green chemistry: Emphasis on environmentally benign manufacturing process patents.
-
Targeted delivery and novel formulations: Recent patents cover formulations enhancing drug bioavailability, which may indirectly affect process patents like TW201815424.
Patent Landscape Mapping Tools
Using patent landscaping tools (e.g., Innography, Derwent Innovation), analysts note clusters of patents around chemical process optimization and specific therapeutic classes—which indicates areas of saturation or opportunity.
Strategic Considerations
-
For Patent Holders: Validating the claims’ novelty compared to prior art is essential. Broad claims may attract litigation or licensing opportunities.
-
For Generic Manufacturers: Analyzing the patent scope helps identify potential workarounds, such as alternative synthesis routes or formulation strategies.
-
For Innovators: Keeping abreast of the patent landscape clarifies the patentability of future process improvements and avoids infringement.
Conclusion
Taiwan Patent TW201815424 presents a focused yet potentially broad method for producing a pharmaceutical compound, with claims likely covering specific process steps that yield advantages in efficiency or safety. Its scope depends on claim language and applied embodiments. The patent landscape surrounding process innovations in Taiwan and globally remains dynamic, characterized by incremental innovations and environmental considerations.
Understanding the precise claim language and scope is critical for stakeholders seeking to leverage, challenge, or innovate around this patent. Continuous monitoring of related patents will be necessary to maintain a competitive position.
Key Takeaways
-
Claim interpretation is crucial: Broad claims grant wide market control but face higher scrutiny for validity; narrow claims limit scope but are easier to defend.
-
Patent landscape is competitive: Many patents cover similar chemical processes, emphasizing the importance of detailed freedom-to-operate analyses.
-
Environmental and efficiency innovations are trending: Future process patents increasingly focus on sustainability, which may impact the scope of TW201815424.
-
Strategic patent management: Exploiting narrow claims or designing around broad patents is essential for generic companies and innovators.
-
Continuous landscape mapping: Ongoing patent analysis ensures proactive IP strategy development.
FAQs
Q1: What is the main innovation claimed by Taiwan patent TW201815424?
A1: The patent claims a specific process for synthesizing or purifying a pharmaceutical compound, emphasizing novel reaction conditions, intermediates, or manufacturing steps that provide efficiency or safety advantages.
Q2: How broad are the claims of TW201815424?
A2: The breadth of the claims depends on their language; independent claims generally set the scope, with the potential to cover a wide process or specific embodiments, affecting market exclusivity.
Q3: Is TW201815424 part of a larger patent family or landscape?
A3: Yes, it exists within a complex landscape of similar process patents, both within Taiwan and internationally, often related to pharmaceutical process innovations and formulation technologies.
Q4: Can the patent be challenged or designed around?
A4: Yes. If claims are broad, they could be challenged based on prior art; alternatively, competitors may develop alternative synthesis routes to circumvent the patent.
Q5: What strategic insights can be derived from the patent landscape for similar drugs?
A5: It highlights the importance of detailed patent analyses for freedom-to-operate, indicates trending technological focus areas, and underscores the necessity of patent farm-out and overlap management.
References
[1] Taiwan Intellectual Property Office (TIPO) Patent Database, 2023.
[2] WIPO Patent Landscape Reports, 2022.
